Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04915365
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04915365
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Kyrgyzstan
- Registry status
- Unknown status
Technical summary
Registry record NCT04915365. Randomized; no masking; primary purpose prevention. Start 2021-05-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude
- Condition
- Right Heart Function
- Condition
- Chronic Obstructive Pulmonary Disease
- Condition
- Altitude Sickness
- Intervention (Drug)
- Acetazolamide
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Zurich
- Collaborator
- National Center of Cardiology and Internal Medicine, Kyrgyz Republic
Record details
- Record id
cardio:ct-nct04915365- Content hash
e640f7acf5d92c3672525bc04ae949d99c05f760755c4812d658bc8d3d837aec